Literature DB >> 1126735

Effect of methionine replacement by homocystine in cultures containing both malignant rat breast carcinosarcoma (Walker-256) cells and normal adult rat liver fibroblasts.

B C Halpern, R Ezzell, D N Hardy, B R Clark, H Ashe, R M Halpern, R A Smith.   

Abstract

When malignant W-256 rat breast carcinosarcoma cells are mixed with an equal number of normal adult rat liver fibroblasts and allowed to grow in a medium containing sufficient L-methionine and an excess of vitamin B12 and of folic acid, the malignant cells outgrow the normal cells, and within 2 weeks the tissue culture flasks contain only neoplastic cells. However, when ample DL-homocystine or homocysteine replaces methionine in the medium containing the same amount of vitamin B12 and folic acid, and seeded with the same type and number of malignant and normal cells, the malignant cells die and the normal cells thrive. Substantiating this conclusion are the results of injections into rats of comparable numbers of cells from each group after 3 weeks of growth in tissue culture. Fatal malignancies are produced by the homocystein-cultivated cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1126735     DOI: 10.1007/bf02615317

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  8 in total

1.  N5-methyltetrahydrofolate: homocysteine methyltransferase activity in extracts from normal, malignant and embryonic tissue culture cells.

Authors:  H Ashe; B R Clark; F Chu; D N Hardy; B C Halpern; R M Halpern; R A Smith
Journal:  Biochem Biophys Res Commun       Date:  1974-03-25       Impact factor: 3.575

2.  Inhibition of neoplastic cell growth by autogenous DNA.

Authors:  R M Halpern; B C Halpern; K A Conklin; R A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

3.  Deranged B 12 metabolism: studies of fibroblasts grown in tissue culture.

Authors:  S H Mudd; B W Uhlendorf; K R Hinds
Journal:  Biochem Med       Date:  1970-11

4.  A growth-modifying factor from cell lines of human malignant origin.

Authors:  D E Rounds
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

5.  Reversal of malignant transformation by tumor DNA.

Authors:  B C Halpern; R M Halpern; S Q Chaney; R A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

6.  The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture.

Authors:  B C Halpern; B R Clark; D N Hardy; R M Halpern; R A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Regulation of 5-methyltetrahydrofolate: homocysteine methyltransferase activity by methionine, vitamin B12, and folate in cultured baby hamster kidney cells.

Authors:  D Kamely; J W Littlefield; R W Erbe
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

8.  Evidence for transfer of enzyme product as the basis of metabolic cooperation between tissue culture fibroblasts of Lesch-Nyhan disease and normal cells.

Authors:  R P Cox; M R Krauss; M E Balis; J Dancis
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

  8 in total
  3 in total

1.  High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine.

Authors:  R M Hoffman; R W Erbe
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  New approach to antifolate treatment of certain cancers as demonstrated in tissue culture.

Authors:  R M Halpern; B C Halpern; B R Clark; H Ashe; D N Hardy; P Y Jenkinson; S C Chou; R A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

3.  Identification and verification of the role of crucial genes through which methionine restriction inhibits the progression of colon cancer cells.

Authors:  Liqiang Zhou; Zhiqing Chen; Chuan Liu
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.